Skip to content
Menu

Incident notification

Coronavirus (COVID-19)

A person conducting a business or undertaking (PCBU) must notify Workplace Health and Safety Queensland (WHSQ) of a confirmed case1 of COVID-19 arising out of the conduct of the business or undertaking:

  • that requires the person to have immediate treatment as an in-patient in a hospital; or
  • the person dies; or
  • to which the carrying out of work is a significant contributing factor, including any infection that is reliably attributable to carrying out work that involves providing treatment or care to a person, or that involves contact with human blood or bodily substances.

If it cannot be determined that work is a 'significant contributing factor' due to the lack of contact tracing then notification is not required. However, WHSQ should be notified of any COVID-19 cases that are reliably understood to be significantly contributed to by work.

WHSQ is continuing to respond to requests for advice or assistance on COVID-19 related matters and our inspectors continue to ensure businesses are complying with requirements to prevent exposure to unacceptable health and safety risks.

To raise a concern about a work health and safety issue, use our online form or call 1300 362 128. For all notifiable incidents to WHSQ, use our incident notification form.

Under the Workers' Compensation and Rehabilitation Act 2003 there is also a requirement for employers to report injuries to insurers within 8 business days, even where the injury does not become a workers’ compensation claim. In the context of COVID-19, the employer would need to be satisfied it has arisen out of, or in the course of employment which may not be relevant in all circumstances but may in others (e.g. a positive case of worker in a team and they all work in a close contact office environment and other team members contract). Read COVID FAQs in relation to claims for workers, employers, lawyers and medical practitioners.

1 A confirmed case is one where there has been a positive PCR test result or a positive Rapid Antigen Test (RAT) result. The RAT test used must be one approved by Therapeutic Goods Administration.